Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer (original) (raw)

• Pardoll, D.M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252–264 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Drake, C.G., Lipson, E.J. & Brahmer, J.R. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat. Rev. Clin. Oncol. 11, 24–37 (2014).
  Article CAS PubMed Google Scholar
• Garon, E.B. et al. Pembrolizumab for the treatment of non-small-cell lung cancer. N. Engl. J. Med. 372, 2018–2028 (2015).
  Article PubMed Google Scholar
• Sharma, P. & Allison, J.P. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell 161, 205–214 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Tumeh, P.C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568–571 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Galon, J. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).
  Article CAS PubMed Google Scholar
• Yang, Y. Cancer immunotherapy: harnessing the immune system to battle cancer. J. Clin. Invest. 125, 3335–3337 (2015).
  Article PubMed PubMed Central Google Scholar
• Baitsch, L. et al. Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients. J. Clin. Invest. 121, 2350–2360 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782–795 (2013).
  Article CAS PubMed Google Scholar
• Collins, N. et al. Transcriptional hallmarks of tumor infiltrating lymphocyte responses to melanoma. Blood 122, 3491 (2013).
  Article Google Scholar
• Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189–196 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Pauken, K.E. & Wherry, E.J. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 36, 265–276 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, I.E., Blank, C., Kline, J., Kacha, A.K. & Gajewski, T.F. Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection. J. Immunol. 177, 4521–4529 (2006).
  Article CAS PubMed Google Scholar
• Montes, C.L. et al. Tumor-induced senescent T cells with suppressor function: a potential form of tumor immune evasion. Cancer Res. 68, 870–879 (2008).
  Article CAS PubMed Google Scholar
• Johnston, R.J. et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8+ T cell effector function. Cancer Cell 26, 923–937 (2014).
  Article CAS PubMed Google Scholar
• Curran, M.A. et al. Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin. J. Exp. Med. 210, 743–755 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Willoughby, J.E. et al. Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunization. J. Immunol. 193, 244–251 (2014).
  Article CAS PubMed Google Scholar
• Topalian, S.L., Drake, C.G. & Pardoll, D.M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27, 450–461 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Gros, A. et al. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors. J. Clin. Invest. 124, 2246–2259 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Fourcade, J. et al. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J. Exp. Med. 207, 2175–2186 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Wolfl, M. et al. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 110, 201–210 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Wherry, E.J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670–684 (2007).
  Article CAS PubMed Google Scholar
• Mackay, L.K. et al. The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin. Nat. Immunol. 14, 1294–1301 (2013).
  Article CAS PubMed Google Scholar
• Mueller, S.N., Gebhardt, T., Carbone, F.R. & Heath, W.R. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 31, 137–161 (2013).
  Article CAS PubMed Google Scholar
• Mackay, L.K. et al. Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. Science 352, 459–463 (2016).
  Article CAS PubMed Google Scholar
• Sathaliyawala, T. et al. Distribution and compartmentalization of human circulating and tissue-resident memory T cell subsets. Immunity 38, 187–197 (2013).
  Article CAS PubMed Google Scholar
• Lee, L.N. et al. CXCR6 is a marker for protective antigen-specific cells in the lungs after intranasal immunization against Mycobacterium tuberculosis. Infect. Immun. 79, 3328–3337 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Tse, S.W., Radtke, A.J., Espinosa, D.A., Cockburn, I.A. & Zavala, F. The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8+ T cells specific for infectious pathogens. J. Infect. Dis. 210, 1508–1516 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Skon, C.N. et al. Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells. Nat. Immunol. 14, 1285–1293 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ariotti, S. et al. T cell memory. Skin-resident memory CD8+ T cells trigger a state of tissue-wide pathogen alert. Science 346, 101–105 (2014).
  Article CAS PubMed Google Scholar
• Schenkel, J.M. et al. T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 346, 98–101 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Best, J.A. et al. Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation. Nat. Immunol. 14, 404–412 (2013).
  CAS PubMed PubMed Central Google Scholar
• Bono, M.R., Fernández, D., Flores-Santibáñez, F., Rosemblatt, M. & Sauma, D. CD73 and CD39 ectonucleotidases in T cell differentiation: beyond immunosuppression. FEBS Lett. 589, 3454–3460 (2015).
  Article CAS PubMed Google Scholar
• Kuhny, M., Hochdörfer, T., Ayata, C.K., Idzko, M. & Huber, M. CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells. Cell Comm. Signal. 12, 40 (2014).
  Article CAS Google Scholar
• Ohta, A. A metabolic immune checkpoint: adenosine in tumor microenvironment. Front. Immunol. 7, 109 (2016).
  Article PubMed PubMed Central CAS Google Scholar
• Gupta, P.K. et al. CD39 expression identifies terminally exhausted CD8+ T cells. PLoS Pathog. 11, e1005177 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Sandoval-Montes, C. & Santos-Argumedo, L. CD38 is expressed selectively during the activation of a subset of mature T cells with reduced proliferation but improved potential to produce cytokines. J. Leukoc. Biol. 77, 513–521 (2005).
  Article CAS PubMed Google Scholar
• Muñoz, P. et al. Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse. Blood 111, 3653–3664 (2008).
  Article PubMed CAS Google Scholar
• Hombrink, P. et al. Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. Nat. Immunol. 17, 1467–1478 (2016).
  Article CAS PubMed Google Scholar
• Faure, M. & Long, E.O. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168, 6208–6214 (2002).
  Article CAS PubMed Google Scholar
• Rajagopalan, S. & Long, E.O. KIR2DL4 (CD158d): an activation receptor for HLA-G. Front. Immunol. 3, 258 (2012).
  Article PubMed PubMed Central Google Scholar
• Wiśniewski, A. et al. Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer. Tissue Antigens 85, 466–475 (2015).
  Article PubMed CAS Google Scholar
• Brooke, G., Holbrook, J.D., Brown, M.H. & Barclay, A.N. Human lymphocytes interact directly with CD47 through a novel member of the signal regulatory protein (SIRP) family. J. Immunol. 173, 2562–2570 (2004).
  Article CAS PubMed Google Scholar
• Piccio, L. et al. Adhesion of human T cells to antigen-presenting cells through SIRPbeta2-CD47 interaction costimulates T-cell proliferation. Blood 105, 2421–2427 (2005).
  Article CAS PubMed Google Scholar
• Wang, Z.Q. et al. CD103 and intratumoral immune response in breast cancer. Clinical Cancer Res. 22, 6290–6297 (2016).
  Article CAS Google Scholar
• Webb, J.R., Milne, K. & Nelson, B.H. Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8+ tumor-infiltrating lymphocytes in ovarian cancer. OncoImmunology 3, e27668 (2014).
  Article PubMed PubMed Central Google Scholar
• Djenidi, F. et al. CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients. J. Immunol. 194, 3475–3486 (2015).
  Article CAS PubMed Google Scholar
• Kurachi, M. et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells. Nat. Immunol. 15, 373–383 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Xin, G. et al. A critical role of IL-21-induced BATF in sustaining CD8-T-cell-mediated chronic viral control. Cell Rep. 13, 1118–1124 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Wolkers, M.C. et al. Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression. Blood 119, 798–804 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Vijayanand, P. et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N. Engl. J. Med. 356, 1410–1422 (2007).
  Article CAS PubMed Google Scholar
• Engel, I. et al. Innate-like functions of natural killer T cell subsets result from highly divergent gene programs. Nat. Immunol. 17, 728–739 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Marsh, D. et al. Stromal features are predictive of disease mortality in oral cancer patients. J. Pathol. 223, 470–481 (2011).
  Article CAS PubMed Google Scholar
• Ward, M.J. et al. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer. Br. J. Cancer 110, 489–500 (2014).
  Article CAS PubMed Google Scholar
• Seumois, G. et al. Transcriptional profiling of Th2 cells identifies pathogenic features associated with asthma. J. Immunol. 197, 655–664 (2016).
  Article CAS PubMed Google Scholar
• Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014).
  Article CAS PubMed Google Scholar
• Trapnell, C., Pachter, L. & Salzberg, S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111 (2009).
  CAS PubMed PubMed Central Google Scholar
• Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Bolotin, D.A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380–381 (2015).
  Article CAS PubMed Google Scholar
• Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545–15550 (2005).
  CAS PubMed PubMed Central Google Scholar
• Safford, M. et al. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 6, 472–480 (2005).
  Article CAS PubMed Google Scholar
• Fridman, A.L. & Tainsky, M.A. Critical pathways in cellular senescence and immortalization revealed by gene expression profiling. Oncogene 27, 5975–5987 (2008).
  Article CAS PubMed Google Scholar